Matthew Roden – Biography
Last update: April 11, 2026Executive profile
Matthew was Executive Partner at MPM BioImpact, and Senior Vice President and Head of Enterprise Strategy at Bristol Myers Squibb.
Matthew Roden is currentlyDirector, President and Chief Executive Officer at Aktis Oncology - View - Aktis Oncology org chart
Entrepreneur Partner at MPM BioImpact - View - MPM BioImpact org chart
Create your alert
to follow the career of Matthew Roden.
Education
Matthew Roden has a Master of Science from Georgetown University and a PhD from Albert Einstein College of Medicine.
They have also studied at Georgetown University :
Find more alumni from Georgetown University
More about Matthew Roden
Selected links
Do you need to know more about Matthew Roden? More results.
Participate
Social media
- Matthew Roden on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Matthew Roden
The colleagues of Matthew Roden
Company Colleagues
- At Aktis Oncology, Matthew Roden has 31 colleagues including Glenn Gormley (Director), Ken Herrmann (Director)…
- At MPM BioImpact, Matthew Roden has 28 colleagues including Christiana Bardon (Managing Partner), Ansbert Gadicke (Managing Partner)…
Industry Colleagues
- In the Fund industry, Matthew Roden has 30,040 colleagues in 1,643 companies located in 64 countries. 10,500 executive movements have been recorded in the last 12 months. Learn more about Fund.
Report an error
Update the org chart details of Matthew Roden.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Matthew Roden.
